1. Ready to Rumble, Ironwood? Activist Investor Alex Denner Suits up for Board-Seat Bid

    Ready to Rumble, Ironwood? Activist Investor Alex Denner Suits up for Board-Seat Bid

    Activist investor Alex Denner is back at it in biopharma. Just a few months after playing a pivotal role in Sanofi’s Bioverativ acquisition, he has set his sights on Ironwood Pharmaceuticals. The Massachusetts drugmaker on Monday said it had received word from Denner’s Sarissa Capital Management, which held 1.92 million Ironwood shares at the end of 2017, that it intended to nominate Denner for Ironwood’s board...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned